BRAT1 and neoplasm: Curcusone D (CurD) leads to an impaired DDR, reduced cancer cell migration, and potentiated activity of the DNA damaging drug etoposide, in HeLa, MCF-7 and MDA-MB-231 cells, indicating a potential role of BRAT1 in therapy responses and tumor growth.